InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Hankey Don, Président du Conseil. Insider active across 1 company, notably Bone Biologics Corp. Cumulatively, 2 disclosures have been logged. History available since 15 October 2021. The latest transaction was filed on 13 March 2023 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Don Hankey is the Chairman of the Board of Bone Biologics Corp. As the leader of the board, he is responsible for overseeing the company's activities and strategic direction. Hankey brings extensive business and governance experience, helping to guide the vision and objectives of Bone Biologics. His commitment to excellence is essential for the organization's success.